Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Multiple Administration Study of TAK-448 in Patients with Prostate Cancer
jRCT2080220949Phase 1
- Sponsor
- Takeda
- Start
- Dec 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, single-arm trial of TAK-448 in prostate cancer (PCa), sponsored by Takeda.
02
Drugs
TAK-448
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on jRCT2080220949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220949.